Citadel Advisors
NH

Citadel Advisors’s NantHealth, Inc NH Stock Holding History

Citadel Advisors’s Portfolio NH Stock Details NH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,073
Closed -$72K – 15064
2021
Q2 		$72K Sell
2,073
-914
-31% -$36.3K ﹤0.01% 13149
2021
Q1 		$144K Sell
2,987
-1,280
-30% -$74.2K ﹤0.01% 12097
2020
Q4 		$207K Buy
4,267
+2,874
+206% +$108K ﹤0.01% 9687
2020
Q3 		$49K Buy
1,393
+186
+15% +$10.5K ﹤0.01% 9611
2020
Q2 		$83K Buy
+1,207
New +$48.1K ﹤0.01% 9094

Other funds holding NH

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Citadel Advisors's NH Position: Q4 2022 in Review

Citadel Advisors sold out of NantHealth, Inc (NH) in Q4 2022, closing a stake of 3,197 shares — an estimated $12K sold.

Citadel Advisors first reported a position in NH in Q1 2017 and held it in 14 quarters. The position peaked at $152K in Q1 2021. 18 funds tracked by Wall St. Rank hold NH as of Q4 2022.

  • Citadel Advisors reported no remaining NantHealth, Inc position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 3,197 NantHealth, Inc shares in Q4 2022, an estimated $12K.
  • Citadel Advisors first reported a position in NantHealth, Inc in Q1 2017 and held it in 14 quarters.
  • Citadel Advisors's NantHealth, Inc position peaked at $152K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held NantHealth, Inc as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.